Role of TLR3/TLR4 and NF-kB in BAG2 mediated phosphorylated Tau degradation

• Main Author: Kamble, Praful Narayan
• Other Authors: Carrettiero, Daniel Carneiro
• Format: Others
• Language: Inglês
• Published: 2015
• Subjects: BAG2; TLR3; SH-SY5Y; PROGRAMA DE PÓS-GRADUAÇÃO EM NEUROCIÊNCIA E COGNIÇÃO - UFABC
• Online Access: http://www.biblioteca.ufabc.edu.brhttp://biblioteca.ufabc.edu.br/index.php?codigo_sophia=97416

Orientador: Prof. Dr. Daniel Carneiro Carrettiero === Tese (doutorado) - Universidade Federal do ABC, Programa de Pós-Graduação em Neurociência e Cognição, 2015. === Doenca de Alzheimer (DA) e uma doenca neurodegenerativa progressiva provocada por perda de sinapses e neuronios, caracterizado por disfuncao da memoria e comprometimento cognitivo global. O anormalmente hiperfosforilada, insoluvel, a proteina tau filamentosa mostrou-se ser o componente principal de emaranhados neurofibrilares, uma caracteristica patologica da DA. Neuroinflamacao e o indutor secundario resposta patologica a deposicao de A e morte celular neuronal associada com DA. Pesquisas documentaram o envolvimento de receptores Toll-like (TLRs) na neuroinflamacao, contribuindo para a patogenese da DA. Todos os TLR ativam as vias inflamatorias conservadas, ativando adicionalmente o Fator Nuclear-kB (NF-kB), resultando na libertacao e a producao de citocinas pro-inflamatorias. Entre a familia TLR, varios estudos indicaram o envolvimento de TLR3 e TLR4 contribuindo para neuroinflamacao. Alem disso, um corpo de dados indica o envolvimento de BAG2 na degradacao da tau fosforilada. Neste contexto, foi investigado o papel de TLR3 e TLR4 na modulacao da BAG2 promovida a degradacao de p-Tau em celulas SH-SY5Y. Neste estudo utilizamos LPS e pIpC para ativar TLR4 e TLR3 respectivamente. Linha de celulas SH-SY5Y foi usadae estabelecendo que o Tau induza a formacao de microtubulos sem limites que esta de acordo com a sua funcao como uma proteina associada amicro tubulos em DA. E tambem, utilizaram-se as celulas SH-SY5Y indiferenciadas uma vez que a expressao de BAG2 e inferior e indiferenciada, em comparacao com celulas diferenciadas. Neste estudo, a ativacao de TLR3 com diferentes concentracoes dem pIpC (1, 10, 50 e 100¿Êg/ml) resultou na regulacao negativa significativa de p-Tau em BAG2 expressao excessiva. Por outro lado, a ativacao de TLR4 com diferentes concentracoes de LPS (10, 50 e 100¿Êg/ml) resultaram em diminuicao dependente da dose na BAG2 expressao excessiva. Alem disso, usou-se JSH-23 para a inibicao de NF-kB. JSH-23 a uma concentracao de 25¿ÊM mostraram regulacao negativa significativa em p-Tau independente do BAG2 expressao excessiva e/ou a estimulacao de TLR3 e TLR4. Inibicao de NF-kB com JSH-23 25¿ÊM resultou na supra regulacao de transcricao significativa BAG2 endogena resultando na degradacao de ptau. Em contraste, a inibicao do NF-kB resultou na supra regulacao de HMW p-tau. BAG2 exogeno sobre a estimulacao TLR4 resultou nodecrescimo da regulacao de HMW p-tau. No entanto JSH-23 endogena induzida BAG2 falhou para regular negativamente HMW p-tau. A ativacao de TLR3/TLR4 nao mostrou toxicidade celular, nem a fosforilacao tau nas celulas SHSY5Y. Alem disso, a estimulacao por LPS na presenca/ausencia de sobre expressao BAG2 nao participa na proliferacao celular. No geral, os resultados demonstram a modulacao BAG2 em TLR4 e TLR3 estimulacao e inibicao de NF-kB degradacao em p-Tau e ou HMW p-Tau em DA. === Alzheimer¿s disease (AD) is a neurodegenerative disorder caused by progressive loss of synapses and neurons, characterized by memory dysfunction and global cognitive impairment. The abnormally hyperphosphorylated, insoluble, filamentous tau protein was shown to be the main component of NFTs, a pathological hallmark of AD. Neuroinflammation is the pathological secondary inducer response to deposition of A and neuronal cell death associated with AD. Considerable research has documented the involvement of Toll-like receptors (TLRs) in neuroinflammation, contributing to the pathogenesis of AD. All TLRs activate conserved inflammatory pathways, further activating nuclear factor-kB (NF-kB) resulting in the release and production of pro-inflammatory cytokines. Among the TLRs family, several studies have indicated the involvement of TLR3 and TLR4 contributing to neuroinflammation. Furthermore, a body of data indicates the involvement of BAG2 in phosphorylated Tau degradation. In this context we investigated the role of TLR3 and TLR4 in modulation of BAG2 promoted p-Tau degradation in SH-SY5Y cells. In this study we used LPS and pIpC to activate TLR4 and TLR3 respectively. SH-SY5Y cell line was used since it is established that the Tau induces the formation of microtubule bundles which is in accord with its function as a microtubule-associated protein in AD. And also, we used undifferentiated SH-SY5Y cells since the expression of BAG2 is lower in undifferentiated as compared to differentiated cell. In this study, activation of TLR3 with different concentration of pIpC (1, 10, 50 and 100ìg/mL) resulted in significant downregulation of p-Tau on BAG2 overexpression. On the other hand, activation of TLR4 with different concentration of LPS (10, 50 and 100ìg/mL) resulted in dose dependent decrease on BAG2 overexpression. . Further we used JSH-23 for NF-kB inhibition. JSH-23 at a concentration of 25ìM showed significant downregulation in p-Tau independent of BAG2 overexpression and/or on TLR4 and TLR3 stimulation. NF-kB inhibition with JSH-23 25ìM resulted in significant upregulation of endogenous BAG2 transcript resulting in p-Tau degradation. In contrast, NF-kB inhibition resulted in upregulation of HMW p-Tau. Exogenous BAG2 on TLR4 stimulation resulted in downregulation of HMW p-Tau. However JSH-23 induced endogenous BAG2 failed to downregulate HMW p-Tau. Activation of TLR3/TLR4 neither showed cell toxicity nor Tau phosphorylation in SH-SY5Y cells. Further LPS stimulation in presence/absence of BAG2 overexpression does not participate in cell proliferation. Overall, our findings demonstrate BAG2 modulation on TLR4 and TLR3 stimulation, and NF-kB inhibition in p-Tau and/or HMW p-Tau degradation in AD.